Thursday, April 18, 2013

Treatment for Novel Coronavirus Shows Promise in Early Lab Tests

National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells. These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding. The study appears in the April 18, 2013, issue of Scientific Reports.

Read more:
Treatment for Novel Coronavirus Shows Promise in Early Lab Tests



























Source: NIH

Art and Science of Laboratory Medicine

Twitter: LaboratoryEQAS
at

1 comment:

  1. RAWDA RUTH SARRAILApril 18, 2013 at 7:12 PM

    * Synergestic Effect (ribavirin & interferon alpha 2b)could be used to treat patients infected with the new coronavirus. More reserach needed to confirm Prelimenary finding.~

    ReplyDelete